All Type of News
Silent Alvogen Korea’s similar packaging causes dispending mistakesMost of the Avogen Korea’s products were observed to distract the pharmacy world similar packaging and design.
The company, however, have not shown responses to the complaints ...
|
Multinational pharma companies’ MRs receive KRW 60 million as daily expenses
It was observed multinational pharmaceutical companies’ medical representatives(MRs) have received KRW 60 thousand at most as daily activity costs, and some companies have paid up to KRW 3 million as self-development ...
New biomedicines & precision medicine selected as national strategic project
9 industries including new biomedicine development and precision medicine were selected as a national strategic project which will lead the future of Korea.
The Ministry of Health and Welfare(Minister Jin-yup Jeong, ...
Co-marketing benefits pharmaceutical companies, but not over defective products
While domestic pharmaceutical companies cannot ignore sales, pharmacies and the distribution industry are sales tools for multinational companies. However, they have had so many complaints since co-marketed and co-pro...
‘Acute renal impairment’ warning added on Forxiga & Invokana
The Ministry of Food and Drug Safety(MFDS) gave an advance notice in regards to changes in the approval details of antidiabetic SGLT-2 inhibitors, ‘Forxiga(dapagliflozin)’ and ‘Invokana(canagliflozin)’ with the proces...
Pharmaceutical public advertisement market hit peak
The pharmaceutical public advertising market has hit its peak. Advertising expenses of major pharmaceutical companies focusing on public advertisements were increased by 80% this year. With stabilization in the market...
“Kim Young-ran Law is double torture on MRs in pharmaceutical field”
The Kim Young-ran Law will be enforced from the 28th of September on medical representatives(MRs) who are already suffering from the Fair Racing Enforcement and the Compliance Program in the pharmaceutical industry.
...
34 people including Novartis’ CEOs & doctors prosecuted of illegal rebatesAt the prosecution’s rebate investigation on a multinational pharmaceutical company, Novartis, which brought a major issue in the pharmaceutical industry in the first half of th...
|
Loyal(?) Novartis protects ‘precious’ hospital doctors“It was so obvious. As expected, they are only able to cut tails, never a body.”
This was a reaction towards the rebate investigation result against a large global company, Nov...
|
Series of domestic pharmaceuticals’ approvals to start global Phase 1 clinical trials
Domestic pharmaceutical companies are actively attempting to expand to the U.S. and European markets.
According to the industry concerned on the 10th, a series of news have continued about Phase 1 clinical trials ove...
